Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).
Clinical trial NCT00088218 · COMPLETED
Trial details
- NCT number
- NCT00088218
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2008-02-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.